PEPTRON
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Peptron's PT105, a sustained-release Leuprolide, established the bioequivalence with Takeda's Leuplin 2022-11-28 09:00
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC 2021-04-16 20:00
1